Skip to content

Investigating Clinical Trial Participation for Acne Patients

An Assessment of Clinical Trial Experiences of Patients With Acne

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05737758
Enrollment
500
Registered
2023-02-21
Start date
2024-03-31
Completion date
2026-03-31
Last updated
2023-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Keywords

acne

Brief summary

Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This trial will scrutinize the experiences of patients diagnosed with acne as they take part in a separate medical intervention clinical trial. The focus will be on tracking the rates of completion and withdrawal among these individuals. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future acne patients.

Interventions

None listed

Sponsors

Power Life Sciences Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient has been diagnosed with acne * Patient is able to read, understand and provide written Informed Consent * Patient is a minimum of 18 years or older

Exclusion criteria

* Inability to perform regular electronic reporting * Pregnant or lactating women * Has significant intercurrent illness, psychiatric disposition or other factors that, in the opinion of the Investigator or Medical Monitor, precludes participation in the study

Design outcomes

Primary

MeasureTime frame
Number of acne patients who decide to join in a clinical study3 months
Rate of patients who remain in an acne clinical study to completion12 months

Contacts

Primary ContactMichael B Gill
bask@withpower.com4159004227

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026